Parabilis Medicines Inc (PBLS)

Sep 29, 2026

Parabilis Medicines, Inc. (PBLS) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 29, 2026

Sep 21, 2026

PBLS Price Today: Parabilis Medicines, Inc. Stock Price, Quote & Chart | MEXC - MEXC

Sep 21, 2026

Sep 21, 2026

Parabilis Medicines (Nasdaq:PBLS)Stock Analysis - Simply Wall Street

Sep 21, 2026

Sep 17, 2026

48,484 Shares in Parabilis Medicines, Inc. $PBLS Acquired by Squarepoint Ops LLC - marketbeat.com

Sep 17, 2026

Sep 10, 2026

Parabilis Medicines (PBLS) Short Interest & Short Float | Updated Sep 2026 - MarketBeat

Sep 10, 2026

Sep 07, 2026

1,920,805 Shares in Parabilis Medicines, Inc. $PBLS Purchased by Frazier Life Sciences Management L.P. - MarketBeat

Sep 07, 2026

Sep 01, 2026

Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Yahoo Finance

Sep 01, 2026

Aug 31, 2026

ICONIQ Capital LLC Takes $9.58 Million Position in Parabilis Medicines, Inc. $PBLS - MarketBeat

Aug 31, 2026

Aug 29, 2026

Regeneron Pharmaceuticals Inc. Buys New Stake in Parabilis Medicines, Inc. $PBLS - marketbeat.com

Aug 29, 2026

Aug 28, 2026

Parabilis Medicines, Inc. (PBLS) Stock Price & News - Syfe

Aug 28, 2026

Aug 28, 2026

1,600,937 Shares in Parabilis Medicines, Inc. $PBLS Purchased by General Catalyst Group Management LLC - MarketBeat

Aug 28, 2026

Aug 28, 2026

venBio Partners LLC Takes $144.15 Million Position in Parabilis Medicines, Inc. $PBLS - MarketBeat

Aug 28, 2026

Aug 28, 2026

Jupiter Topco LLC Buys Shares of 2,296,547 Parabilis Medicines, Inc. $PBLS - MarketBeat

Aug 28, 2026

Aug 26, 2026

Parabilis Medicines, Inc. (NASDAQ:PBLS) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Aug 26, 2026

Aug 25, 2026

Parabilis appoints Craig Tendler to its Board and Science & Technology Committee - TradingView

Aug 25, 2026

Aug 25, 2026

Parabilis Medicines adds former J&J oncology executive to board By Investing.com - Investing.com Canada

Aug 25, 2026

Aug 25, 2026

Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors - Yahoo Finance

Aug 25, 2026

Aug 24, 2026

ICONIQ Capital LLC Makes New Investment in Parabilis Medicines, Inc. $PBLS - MarketBeat

Aug 24, 2026

Aug 19, 2026

Parabilis Medicines Price Insights - YCharts

Aug 19, 2026

Aug 18, 2026

Parabilis Medicines (NASDAQ:PBLS) Stock Price Up 5.9%Here's What Happened - MarketBeat

Aug 18, 2026

Aug 18, 2026

Alphabet Inc. Makes New $134.65 Million Investment in Parabilis Medicines, Inc. $PBLS - MarketBeat

Aug 18, 2026

Aug 17, 2026

Biotech’s reverse merger renaissance poised to continue - Endpoints News

Aug 17, 2026

Aug 17, 2026

Parabilis Medicines (NASDAQ:PBLS) Sets New 1-Year HighWhat's Next? - MarketBeat

Aug 17, 2026

Aug 17, 2026

Focus Partners Advisor Solutions LLC Invests $1.35 Million in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 17, 2026

Aug 15, 2026

Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Celcuity (CELC) and Parabilis Medicines, Inc. (PBLS) - The Globe and Mail

Aug 15, 2026

Aug 14, 2026

Parabilis Medicines(PBLS) Stock Options Chain | Quotes & News - Moomoo

Aug 14, 2026

Aug 14, 2026

Parabilis Medicines(PBLS) Stock Options Chain | Quotes & News - Moomoo

Aug 14, 2026

Aug 14, 2026

Parabilis Medicines (PBLS): ARCH Venture group discloses 6.4M-share, 5.3% ownership - Stock Titan

Aug 14, 2026

Aug 14, 2026

BofA Securities Maintains Parabilis Medicines(PBLS.US) With Buy Rating - Moomoo

Aug 14, 2026

Aug 14, 2026

Parabilis Medicines: A Rare-Tumor Validation Ladder For An Undruggable Platform (NASDAQ:PBLS) - Seeking Alpha

Aug 14, 2026

Aug 14, 2026

Parabilis Medicines, Inc. Common Stock (NASDAQ: PBLS) Stock Price, News & Analysis - kalkine.ca

Aug 14, 2026

Aug 14, 2026

Parabilis Medicines, Inc. Common Stock (NASDAQ: PBLS) Stock Price, News & Analysis - kalkine.com.au

Aug 14, 2026

Aug 14, 2026

PBLS SWOT Analysis: Financial Resilience Amidst Clinical Challen - GuruFocus

Aug 14, 2026

Aug 13, 2026

Parabilis Medicines (PBLS) Earnings Date and Reports 2026 - MarketBeat

Aug 13, 2026

Aug 13, 2026

Parabilis Medicines (PBLS) boosts cash above $1.1B after IPO and Regeneron deal - Stock Titan

Aug 13, 2026

Aug 13, 2026

Form 8K Parabilis Medicines For: 13 August By Investing.com - Investing.com Nigeria

Aug 13, 2026

Aug 13, 2026

PBLS: Lead asset zolucatetide shows strong efficacy and safety, driving a robust pipeline and growth - TradingView

Aug 13, 2026

Aug 13, 2026

Form 8K Parabilis Medicines For: 13 August By Investing.com - Investing.com South Africa

Aug 13, 2026

Aug 13, 2026

Parabilis Medicines Q2 Loss Narrows; Shares Rise Pre-Bell - marketscreener.com

Aug 13, 2026

Aug 13, 2026

Earnings Flash (PBLS) Parabilis Medicines Posts Q2 Net Loss $2.32 a Share - marketscreener.com

Aug 13, 2026

Aug 13, 2026

Form 8K Parabilis Medicines For: 13 August By Investing.com - Investing.com Canada

Aug 13, 2026

Aug 13, 2026

Form 8K Parabilis Medicines For: 13 August By Investing.com - Investing.com Australia

Aug 13, 2026

Aug 13, 2026

Form 8K Parabilis Medicines For: 13 August By Investing.com - Investing.com India

Aug 13, 2026

Aug 13, 2026

Parabilis Medicines Reports Second Quarter 2026 Financial Results And Provides Business Updates - TradingView

Aug 13, 2026

Aug 13, 2026

Form 8K Parabilis Medicines For: 13 August By Investing.com - Investing.com UK

Aug 13, 2026

Aug 13, 2026

Earnings Flash (PBLS) Parabilis Medicines, Inc. Reports Q2 Revenue $148,000 - marketscreener.com

Aug 13, 2026

Aug 13, 2026

Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates - The Manila Times

Aug 13, 2026

Aug 13, 2026

Parabilis Medicines Advances Zolucatetide Toward Phase 3 in Desmoid Tumors, Announces Regeneron Collaboration and $1.1 Billion Cash Position - Quiver Quantitative

Aug 13, 2026

Aug 13, 2026

Parabilis Medicines: Q2 Earnings Snapshot - marketscreener.com

Aug 13, 2026

Aug 13, 2026

Parabilis Medicines: Q2 Earnings Snapshot - AOL.com

Aug 13, 2026